This competing renewal application proposes continuation of the UCSF-Kaiser Department of Research (DOR) Bridging Interdisciplinary Research Careers in Women's Health (BIRCWH) K-12 Program. The program's aims are to: 1. recruit a superb and diverse group of early career Women's Health researchers; 2. provide them fiscal and individually-tailored training and mentoring; 3. build upon our existing program by broadening it to specifically target important Women's Health topics that are understudied; 4. strengthen and integrate models of multidisciplinary research and develop researchers who foster linkages across disciplines and institutions;and 5. to promote the prominence of and resources allocated to Women's Health research by mentoring BIRCWH Scholars and alumni in academic process and leadership. The program is multidisciplinary, including scholars and faculty mentors from each of the UCSF schools and Kaiser-DOR. It emphasizes novel interdisciplinary approaches to a wide range of Women's Health issues. The program will continue its strong initiatives in Women's Cancer, bone disease and menopause. New foci draw upon the unique strengths of UCSF and Kaiser-DOR and include Occupational and Environmental Health;Addiction, Violence and Traumatic Stress;Aging and Dementia;Autoimmunity;Metabolism and Obesity;Maternal Health and Child Outcomes and Muscular and Skeletal Health. A multidisciplinary Advisor Committee oversees the program in partnership with leadership, including selection of new BIRCWH scholars. The program emphasizes multidisciplinary mentoring teams that cross disciplines and research methodologies. The diversity of scholars, in terms of fields of interest, background, training, ethnicity and gender is a priority. A special emphasis for this renewal is placed on the cultural and ethnic diversity of scholars and affiliated faculty. BIRCWH scholars participate in program-specific seminars, assessments of progress and mentoring activities. In addition, the program integrates in UCSF CTSI career development and training programs. The career development path for each scholar is tailored to the specific types of experience and mentoring that will most effectively support her or his transition to an independent clinical scientist. This renewal features a new emphasis on leadership development that will assess the academic progress of BIRCWH alumni and facilitate leadership training for those who qualify. The program overall will continue to be a unique resource for the continuation and expansion of Women's Health Science in the San Francisco Bay Area.

Public Health Relevance

The UCSF-Kaiser Department of Research (DOR) Bridging Interdisciplinary Research Careers in Women's Health (BIRCWH) Program provides career development mentoring and training of scholars as an independent Women's Health scientists, broadens the range of Women's Health research, and supports the development of academic leaders in Women's Health.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
5K12HD052163-12
Application #
8125132
Study Section
Special Emphasis Panel (ZRG1-PSE-H (50))
Program Officer
Davis Nagel, Joan
Project Start
2000-09-20
Project End
2015-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
12
Fiscal Year
2011
Total Cost
$500,001
Indirect Cost
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Saberi, Parya; Neilands, Torsten B; Ming, Kristin et al. (2017) Strong Correlation Between Concentrations of Antiretrovirals in Home-Collected and Study-Collected Hair Samples: Implications for Adherence Monitoring. J Acquir Immune Defic Syndr 76:e101-e103
Gandhi, Monica; Murnane, Pamela M; Bacchetti, Peter et al. (2017) Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen. AIDS 31:2245-2251
Kajubi, R; Huang, L; Jagannathan, P et al. (2017) Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention. Clin Pharmacol Ther 102:520-528
Vafai, Yassaman; Steinberg, Julia R (2017) The effects of pre-abortion depressive symptoms on post-abortion contraceptive effectiveness level chosen among women seeking abortions. Contraception :
Pintye, Jillian; Bacchetti, Peter; Teeraananchai, Sirinya et al. (2017) Brief Report: Lopinavir Hair Concentrations Are the Strongest Predictor of Viremia in HIV-Infected Asian Children and Adolescents on Second-Line Antiretroviral Therapy. J Acquir Immune Defic Syndr 76:367-371
Koss, Catherine A; Bacchetti, Peter; Hillier, Sharon L et al. (2017) Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations. AIDS Res Hum Retroviruses :
El Ayadi, Alison M; Rocca, Corinne H; Kohn, Julia E et al. (2017) The impact of an IUD and implant intervention on dual method use among young women: Results from a cluster randomized trial. Prev Med 94:1-6
Koss, Catherine A; Natureeba, Paul; Kwarisiima, Dalsone et al. (2017) Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda. J Acquir Immune Defic Syndr 74:279-284
Smoot, Betty; Paul, Steven M; Aouizerat, Bradley E et al. (2016) Predictors of Altered Upper Extremity Function During the First Year After Breast Cancer Treatment. Am J Phys Med Rehabil 95:639-55
Gerona, Roy; Wen, Anita; Koss, Catherine et al. (2016) A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs. Int J Tuberc Lung Dis 20:991-2

Showing the most recent 10 out of 109 publications